HIV immunology core supporting antibody and immune response work

Core 3 - Immunobiology Core

NIH-funded research Duke University · NIH-11397293

This team uses lab tests and antibody-sorting to help scientists see how HIV's outer protein changes and how the immune system reacts in people living with HIV.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionDuke University NIH-funded
Lab location1 site (Durham, United States)
Project IDNIH-11397293 on NIH RePORTER

What this research studies

This immunobiology core provides centralized lab services to study how the HIV-1 Envelope (Env) protein changes during infection and how B cells and T cells respond. The team runs cellular and molecular immune tests, measures peptide presentation on MHCII, and examines B cell receptor signaling in cell lines and engineered mice. They also perform single B cell sorting from people with HIV to recover and produce Env-specific antibodies. The core supports multiple projects at the Duke Center for HIV Structural Biology to link viral structure to immune responses.

Who could benefit from this research

Good fit: Ideal participants are adults living with HIV who can provide blood samples and share basic treatment and health history.

Not a fit: People without HIV or those looking for immediate clinical treatment changes should not expect direct personal medical benefit from this lab-focused core.

Why it matters

Potential benefit: If successful, this work could help identify antibodies and immune mechanisms that lead to better vaccines or curative strategies for people with HIV.

How similar studies have performed: Methods like single B cell sorting and antibody isolation have previously led to discovery of broadly neutralizing HIV antibodies, so the approach builds on proven techniques.

Where this research is happening

Durham, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome Virus
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.